Investigational Product Compliance-Lapatinib, Investigational Product Discontinuation

Investigational Product Compliance-Lapatinib
Descrição

Investigational Product Compliance-Lapatinib

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1321605
Date Investigational Product dispensed
Descrição

Date Investigational Product dispensed

Tipo de dados

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0947323
UMLS CUI [1,3]
C0304229
Total Number Dispensed
Descrição

Total Number Dispensed

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0805077
UMLS CUI [1,2]
C0304229
Date investigatinal Product returned
Descrição

Date investigatinal Product returned

Tipo de dados

date

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C2826249
Total number returned
Descrição

Total number returned

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2699071
UMLS CUI [1,2]
C0039225
Investigational Product Discontinuation
Descrição

Investigational Product Discontinuation

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0457454
Investigational Product
Descrição

Investigational Product

Tipo de dados

integer

Alias
UMLS CUI [1]
C0304229
Was the investigational product stopped permanently before the end of the scheduled treatment period?
Descrição

Investigational product stopped permanently before the end of the scheduled treatment period

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0457454
If yes, specify the primary reason the investigational product was stopped
Descrição

Specify the primary reason the investigational product was stopped

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C0457454

Similar models

Investigational Product Compliance-Lapatinib, Investigational Product Discontinuation

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Investigational Product Compliance-Lapatinib
C0304229 (UMLS CUI-1)
C1321605 (UMLS CUI-2)
Date Investigational Product dispensed
Item
Date Investigational Product dispensed
date
C0011008 (UMLS CUI [1,1])
C0947323 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Total Number Dispensed
Item
Total Number Dispensed
text
C0805077 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Date investigatinal Product returned
Item
Date investigatinal Product returned
date
C0013230 (UMLS CUI [1,1])
C2826249 (UMLS CUI [1,2])
Total number returned
Item
Total number returned
text
C2699071 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
Item Group
Investigational Product Discontinuation
C0304229 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
Item
Investigational Product
integer
C0304229 (UMLS CUI [1])
Code List
Investigational Product
CL Item
Lapatinib (1)
CL Item
Paclitaxel (2)
Investigational product stopped permanently before the end of the scheduled treatment period
Item
Was the investigational product stopped permanently before the end of the scheduled treatment period?
boolean
C0304229 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
Item
If yes, specify the primary reason the investigational product was stopped
integer
C0392360 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
Code List
If yes, specify the primary reason the investigational product was stopped
CL Item
Adverse evetn, record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor termined study (6)
CL Item
Disease progression (7)
CL Item
Death (25)
CL Item
Subject decided to withdraw from IP but is to be followed for survival per protocol (27)
CL Item
Other, Specify (0)